"Ketamine's Evolving Role in Mental Health Treatment"

A recent study conducted across four major U.S. medical institutions found that ketamine infusions led to significant improvements in depressive symptoms, including suicidality, in individuals who had not responded to conventional treatments. The study, part of a larger project seeking blood-based biomarkers of treatment response, showed that approximately 52% of participants achieved remission, with a substantial decrease in suicidal thoughts and anhedonia. While the study lacked a control group and was open-label, the results provide promising evidence for ketamine as an effective treatment for severe depression, with potential for identifying biological markers associated with treatment response.